|Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study|
J Staaf, D Glodzik, A Bosch, J Vallon-Christersson, C Reuterswärd, ...
Nature medicine 25 (10), 1526-1533, 2019
|Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic|
C Winter, MP Nilsson, E Olsson, AM George, Y Chen, A Kvist, T Törngren, ...
Annals of Oncology 27 (8), 1532-1538, 2016
|The Sweden Cancerome Analysis Network-Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the …|
LH Saal, J Vallon-Christersson, J Häkkinen, C Hegardt, D Grabau, ...
Genome medicine 7 (1), 1-12, 2015
|Clinical value of RNA sequencing–based classifiers for prediction of the five conventional breast cancer biomarkers: a report from the population-based multicenter Sweden …|
C Brueffer, J Vallon-Christersson, D Grabau, A Ehinger, J Häkkinen, ...
JCO Precision Oncology 2, 1-18, 2018
|Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival|
NP Tobin, JC Harrell, J Lövrot, SE Brage, MF Stolt, L Carlsson, Z Einbeigi, ...
Annals of oncology 26 (1), 81-88, 2015
|Refinement of breast cancer molecular classification by miRNA expression profiles|
R Søkilde, H Persson, A Ehinger, AC Pirona, M Fernö, C Hegardt, ...
BMC genomics 20 (1), 1-12, 2019
|An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and …|
D Weller, P Vedsted, C Anandan, A Zalounina, EO Fourkala, R Desai, ...
BMJ open 6 (7), e009641, 2016
|Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial|
J Bjöhle, J Bergqvist, JS Gronowitz, H Johansson, L Carlsson, Z Einbeigi, ...
Breast cancer research and treatment 139 (3), 751-758, 2013
|Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer …|
D Weller, U Menon, AZ Falborg, H Jensen, A Barisic, AK Knudsen, ...
BMJ open 8 (11), e023870, 2018
|Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial|
T Hatschek, L Carlsson, Z Einbeigi, E Lidbrink, B Linderholm, B Lindh, ...
Breast cancer research and treatment 131 (3), 939-947, 2012
|Immune gene expression and response to chemotherapy in advanced breast cancer|
T Foukakis, J Lövrot, A Matikas, I Zerdes, J Lorent, N Tobin, C Suzuki, ...
British journal of cancer 118 (4), 480-488, 2018
|Advanced‐stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross‐sectional study|
ML Tørring, AZ Falborg, H Jensen, RD Neal, D Weller, I Reguilon, ...
European Journal of Cancer Care 28 (5), e13100, 2019
|Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series|
J Vallon-Christersson, J Häkkinen, C Hegardt, LH Saal, C Larsson, ...
Scientific reports 9 (1), 1-16, 2019
|Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative|
L Rydén, N Loman, C Larsson, C Hegardt, J Vallon-Christersson, ...
Journal of British Surgery 105 (2), e158-e168, 2018
|Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers|
D Glodzik, A Bosch, J Hartman, M Aine, J Vallon-Christersson, ...
Nature communications 11 (1), 1-15, 2020
|Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment|
Anticancer Res. 11, 873-875, 1991
|Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer|
C Lundgren, PO Bendahl, Å Borg, A Ehinger, C Hegardt, C Larsson, ...
Breast cancer research and treatment 178 (2), 459-467, 2019
|The determination of growth rates of individual colonies in agarose using high‐resolution automated image analysisx|
HK Slocum, M Malmberg, WR Greco, JC Parsons, YM Rustum
Cytometry: The Journal of the International Society for Analytical Cytology …, 1990
|Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: development and validation within a population-based cohort|
L Dihge, J Vallon-Christersson, C Hegardt, LH Saal, J Häkkinen, ...
Clinical Cancer Research 25 (21), 6368-6381, 2019
|Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer|
M Klintman, S Ørnbjerg Würtz, IJ Christensen, P Bræmer Hertel, M Fernö, ...
Breast cancer research and treatment 121 (2), 365-371, 2010